These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 35761386)
1. EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA. Shuang O; Zhou J; Cai Z; Liao L; Wang Y; Wang W; Xu M J Orthop Surg Res; 2022 Jun; 17(1):332. PubMed ID: 35761386 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis. Li C; Lin X; Zhang C; Wan L; Yin J; Wang B Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267 [TBL] [Abstract][Full Text] [Related]
3. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling. Yang Y; Dong MH; Hu HM; Min QH; Xiao L Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964 [TBL] [Abstract][Full Text] [Related]
4. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p. Aichen Z; Kun W; Xiaochun S; Lingling T Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma. Fei D; Yuan H; Zhao M; Zhao D Cell Biol Int; 2022 Nov; 46(11):1937-1946. PubMed ID: 36041209 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e. Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696 [TBL] [Abstract][Full Text] [Related]
7. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis. Li B; Yu X; Pang F Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964 [TBL] [Abstract][Full Text] [Related]
8. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533 [TBL] [Abstract][Full Text] [Related]
9. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis. Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241 [TBL] [Abstract][Full Text] [Related]
10. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis. Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727 [TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis. Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920 [TBL] [Abstract][Full Text] [Related]
12. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma. Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461 [TBL] [Abstract][Full Text] [Related]
13. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC). Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947 [TBL] [Abstract][Full Text] [Related]
14. lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7. Xue Y; Liu H; Nie G; Ren X Dis Markers; 2022; 2022():4660217. PubMed ID: 35422889 [TBL] [Abstract][Full Text] [Related]
15. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145. Zhou Y; Feng D; Gu X; Gao A; Liu Y Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416 [TBL] [Abstract][Full Text] [Related]
16. FXR1 promotes glioma progression by downregulating microRNA-124-3p through long noncoding RNA FGD5-AS1 upregulation. Gong X; Huang M; Chen L; Zeng H Acta Neurol Belg; 2023 Aug; 123(4):1453-1464. PubMed ID: 37074635 [TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis. Xie C; Chen B; Wu B; Guo J; Cao Y Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327 [TBL] [Abstract][Full Text] [Related]
18. LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2. Yang Z; Liu Z; Lu W; Guo H; Chen J; Zhang Y Biol Direct; 2023 Nov; 18(1):74. PubMed ID: 37957698 [TBL] [Abstract][Full Text] [Related]
19. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer. Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]